TY - JOUR AU - Rosell, Rafael AU - Karachaliou, Niki AU - Codony-Servat, Carles AU - Ito, Masaoki PY - 2018 TI - Inhibition of MEK, a canonical KRAS pathway effector in KRAS mutant NSCLC JF - Translational Lung Cancer Research; Vol 7, Supplement 3 (September 26, 2018): Translational Lung Cancer Research1 Y2 - 2018 KW - N2 - KRAS mutant NSCLC cells require active nuclear export of Iκβα (also known as NFKBIA), a negative regulatory protein of NF-κB signaling, for maintaining survival signaling (1-3). Nuclear export receptor XPO1 correlates with KRAS mutation status. UR - https://tlcr.amegroups.org/article/view/20503